title: The treatment of steroid-resistant renal allograft rejection with OKT3 and plasmapheresis.
authors.affiliation: Turkish Transplantation and Burn Foundation Medical Center, Ankara.
authors.forename: M
authors.initials: M
authors.lastname: Haberal
authors.forename: S
authors.initials: S
authors.lastname: Sert
authors.forename: H
authors.initials: H
authors.lastname: Gülay
authors.forename: G
authors.initials: G
authors.lastname: Arslan
authors.forename: N
authors.initials: N
authors.lastname: Bilgin
mesh_terms: D000293:Adolescent; D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D004351:Drug Resistance; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection; D006085:Graft Survival; D006801:Humans; D007165:Immunosuppression Therapy; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D016853:Muromonab-CD3; D010956:Plasmapheresis; D013256:Steroids / Q000627:therapeutic use; D014184:Transplantation, Homologous
chemical_list: D000911:Antibodies, Monoclonal; D016853:Muromonab-CD3; D013256:Steroids